Farnham, Surrey, GU97EN, United Kingdom
NCT Number: NCT01579045
Effect of Head and Gaze Position on Soft Toric Contact Lens Performance
Primary Hypotheses:
Senofilcon A will provide significantly less rotation with subjects in a recumbent position than Filcon II 3 monthly .
Etafilcon A will provide significantly less rotation with subjects in a recumbent position than Filcon II 3 1 1 day .
Etafilcon A will provide rotation with subjects a recumbent position non-inferior to nelfilcon A. A margin of 5 degrees will be used.
Secondary Hypotheses:
Senofilcon A will have significantly better monocular visual performance with subjects in a recumbent position than Filcon II 3 monthly.
Etafilcon A for astigmatism will have significantly better monocular visual performance with subjects in a recumbent position than Filcon II 3 1 day.
Etafilcon A will have monocular visual performance with subjects in a recumbent position non-inferior nelfilcon A. A margin of 0.05 LogMAR will be used.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–55 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age range 18-60 years.
- Read, understand, and sign written Statement of Informed Consent.
- Appear able and willing to adhere to the instructions set forth in the clinical protocol.
- Be existing soft contact lens wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed).
- Require a visual correction in both eyes (monovision allowed but no monofit).
- Have a spherical contact lens requirement in the range -1.00 to -6.00D.
- Have astigmatism of between -0.75 and -2.00DC in both eyes.
- Have axes of astigmatism within +/-10° of the following available lens axes: 70°, 90°, 110°, 20°, 180° & 160°, i.e. 60-120, 10-30 and 150-180.
- Monocular distance visual acuity correctable to 6/9 or better in each eye with best sphero-cylindrical refraction.
- Have normal eyes with no evidence of any ocular abnormality or disease. For the purposes of this study a normal eye is defined as one having:
i) Clear cornea ii) No anterior segment disorder iii) No clinically significant slit lamp findings (i.e. edema, staining, scarring, vascularization, infiltrates or abnormal opacities) iv) No other active ocular disease or recent surgery
Exclusion criteria
- Having worn rigid gas permeable (RGP) contact lenses within the last 30 days or polymethyl methacrylate (PMMA) contact lenses within the last 3 months.
- Clinically significant corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
- Extended lens wear in last 3 months.
- Any systemic or topical medications that will in the investigator's opinion affect ocular physiology or contact lens performance.
- Any systemic disease affecting ocular health.
- Abnormal lacrimal secretions.
- Keratoconus or other corneal irregularity.
- Pregnancy, lactating or planning a pregnancy at the time of enrolment.
- Participation in any concurrent clinical trial.
- Any previous anterior ocular surgery.
- Subjects who are known to have an infectious systemic disease (e.g.,hepatitis, tuberculosis).
- Subjects who are known to have an immunosuppressive disease (e.g., HIV positive).
- Subjects who are known to have diabetes.
- Employees or family members of the Research site, Principal Investigator or study team.
Treatment and study plan
Senofilcon A
Devicebilateral daily use soft contact lens
etafilcon A
Devicebilateral daily use soft contact lens
Nelfilcon A
Devicebilateral daily use soft contact lens
filcon II 3
Devicebilateral daily use soft contact lens
Primary outcomes
-
Lens Orientation in Recumbent Position
Time frame: up to 60 minutes in recumbent position
rotation from zero position also described as absolute value of the rotation.
Secondary outcomes
-
Monocular Visual Acuity in Recumbent Position
Time frame: up to 60 minutes in recumbent position
Visual Acuity measured in LogMAR units. High contrast visual acuity (VA) was measured in both eyes using a 3m LogMAR test chart at 2.5m testing distance (subsequently converted).
Sponsors and collaborators
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Industry
Registry information
Important dates
- Study start
- 2012
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Apr 17, 2012
- Registry last updated
- Jun 19, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Short-term Study of Two Soft Contact Lenses in Wearers With Low Astigmatism
NCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial DetailsClinical Investigation of the Cheetah System For The Correction of Myopia With and Without Astigmatism
NCT04200898
Astigmatism, Eye Diseases
Zagreb, City of Zagreb, Croatia
View Trial DetailsA Clinical Evaluation of a Phakic Intraocular Lens
NCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsPost-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure
NCT05740293
Astigmatism, Eye Diseases
Fayetteville, Arkansas, United States
View Trial Details